Business ❯ Pharmaceutical Industry

Research and Development

Clinical Research Cost Reduction Clinical Trials Innovation Investment Collaboration Collaborations Technology Transfer Strategic Decisions Investment Trends

Boehringer’s Survodutide Cuts Body Weight 16.6% in Phase III Trial

The result strengthens Boehringer’s push to break into a market led by Eli Lilly and Novo Nordisk.

WHO Prequalifies First Malaria Treatment for Newborns

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

OpenAI Launches GPT-Rosalind, a Biology-Tuned AI for Drug Discovery

Mexico, Pfizer Sign Deal to Produce mRNA Covid Vaccines in Toluca by Winter 2027-2028

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

India Notifies Risk-Based Overhaul of Drug R&D Rules

Okava Launches First GLP-1 Implant Trial for Overweight Cats

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Scientists Convert Plastic Waste Into Paracetamol With 92% Yield

SPARC Shares Plunge Nearly 20% After Failed Phase 2 Vibozilimod Trials

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

FDA Launches Immediate Plan to Replace Animal Testing with Human-Relevant Methods

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

GSK and Oxford University Partner on £50M Cancer Vaccine Research